Sex Effects in Mouse Prion Disease Incubation Time by Akhtar, Shaheen et al.
Sex Effects in Mouse Prion Disease Incubation Time
Shaheen Akhtar, Adam Wenborn, Sebastian Brandner, John Collinge, Sarah E. Lloyd*
Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom
Abstract
Prion disease incubation time in mice is determined by many factors including PrP expression level, Prnp alleles, genetic
background, prion strain and route of inoculation. Sex differences have been described in age of onset for vCJD and in
disease duration for both vCJD and sporadic CJD and have also been shown in experimental models. The sex effects
reported for mouse incubation times are often contradictory and detail only one strain of mice or prions, resulting in broad
generalisations and a confusing picture. To clarify the effect of sex on prion disease incubation time in mice we have
compared male and female transmission data from twelve different inbred lines of mice inoculated with at least two prion
strains, representing both mouse-adapted scrapie and BSE. Our data show that sex can have a highly significant difference
on incubation time. However, this is limited to particular mouse and prion strain combinations. No sex differences were
seen in endogenous PrP
C levels nor in the neuropathological markers of prion disease: PrP
Sc distribution, spongiosis,
neuronal loss and gliosis. These data suggest that when comparing incubation times between experimental groups, such as
testing the effects of modifier genes or therapeutics, single sex groups should be used.
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Introduction
Prion diseases or transmissible spongiform encephalopathies
involve the conversion of the normal host PrP
C to an abnormal
form, PrP
Sc. They are a group of fatal neurodegenerative diseases
that affect both humans and animals and include sheep scrapie,
bovine spongiform encephalopathy (BSE) in cattle and Creutz-
feldt-Jakob disease (CJD) in humans [1]. Human prion diseases
have three distinct aetiologies: sporadic, inherited and acquired.
Sporadic CJD is the most common form of human prion disease
accounting for ,85% of all cases and to date there is no known
cause. 15% of cases are inherited or familial and are caused by
mutations in the prion gene (PRNP). Prion diseases are also
infectious and are therefore transmissible (acquired). Human prion
diseases have been transmitted through medical procedures
(iatrogenic) such as the administration of contaminated pituitary
hormones and the use of infected neurosurgical electrodes.
Following human exposure to BSE contaminated material, a
new acquired prion disease, variant CJD (vCJD), was recognised.
Irrespective of aetiology and host, prion diseases are distin-
guished by long, clinically silent incubation periods and charac-
teristic neuropathology such as PrP
Sc accumulation, spongiform
change (vacuolation), gliosis and neuronal death. Prion disease
incubation time in experimental models such as inbred mice is
highly reproducible under standard conditions. However, there is
also considerable variation that is determined by several factors
including host genetic background, prion strain and route of
inoculation. The main genetic determinant is variation in Prnp
itself that results in two major isoforms of PrP: Prnp
a (108L, 189T)
and Prnp
b (108F, 189V) that are associated with short and long
incubation times respectively [2–5]. Comparison of incubation
times from Prnp
a inbred lines shows a difference of over 100 days
between the shortest and longest incubation time strains suggesting
the involvement of additional genetic loci [6]. Several quantitative
trait loci mapping studies have identified regions of the genome
that contain genetic factors that influence incubation time in mice
[7–10] and further fine mapping has identified individual
candidate genes [11–13].
Prion strains are associated with conformational and glycosyl-
ation differences in PrP
Sc and result in different incubation times
even in the same host [14]. Indeed, the characteristic incubation
period, neuropathology and biochemistry form the basis on which
different prion strains are defined [15,16].
The most common route for the inoculation mice with prions is
either intracerebral or intraperitoneal. Delivery of prions directly
to the central nervous system rather than to the periphery results
in shorter incubation times [17,18].
Sex has also been implicated in influencing prion disease
incubation time in mice. This effect has been suggested by a few
studies, however, these have not been comprehensive and have
largely focused on only one strain of mice or prions [19–22].
Variation in the choice of model and prion strain have also
compounded the difficulty of replicating these findings resulting in
equivocal data and a confusing picture. Sex effects have also been
described in human prion diseases with females exhibiting a two
year earlier age of onset than males for vCJD after stratification by
birth cohort [19]. Survival times for females in both CJD and
vCJD have also shown to be longer increasing from four to five
months and twelve to fourteen months respectively [23].
In order to address the effect of sex on prion disease incubation
time in mice we have compared transmission data for males and
females gathered at the MRC Prion Unit over the last ten years.
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inoculated with at least two prion strains representing both mouse
adapted scrapie (Chandler/RML) and mouse adapted BSE. We
show that sex can have a profound influence on incubation time,
however, this is not a general effect and is not seen in all mouse
strains but rather is highly specific for given combinations of
mouse model and prion strain.
Results
Prion transmissions to inbred lines
Groups of males and females from twelve different inbred lines
of mice (including two sub-strains of C57BL/6) were inoculated
intra-cerebrally with various strains of prions. All mouse lines were
challenged with a strain of mouse-adapted scrapie and mouse-
adapted BSE. These were generally Chandler/RML scrapie
prions (I856) and C57BL/6 passaged BSE (I874), however, ME7
scrapie prions (I9459) and mouse-passaged BSE (MRC2, I9468)
were also transmitted in some cases (Table 1). The inbred lines of
mice represent a range of genetic backgrounds and incubation
times ranging from a ‘‘short’’ incubation time strain such as
NZW/OlaHsd to a ‘‘long’’ incubation time strain such as MAI/
Pas. Most strains are Prnp
a allele mice, however, JU/FaCt is a
Prnp
b strain and MAI/pas is a Prnp
c strain [6]. Most mouse lines
are standard laboratory inbred lines with the exception of PERA/
Kamei, CAST/Ei, PWK/Pas and MAI/Pas that are derived from
wild-trapped animals [24].
Incubation times for all transmissions are shown in table 1. For
8 of the 12 mouse lines no significant differences were seen
between males and females with either Chandler/RML or mouse-
passaged BSE prions. For SM/J and NZW/OlaHsd significant
differences were seen between males and females (p,0.0001 and
p=0.006 respectively) with Chandler/RML, but not mouse-
passaged BSE, prions. For SM/J mice the mean incubation time
was 6% longer in females as compared to males, however, the
situation was reversed for NZW/OlaHsd where the mean
incubation time in females was 3% shorter than in males.
Two lines of mice, C57BL/6 and FVB/NHsd, showed
significant sex differences with multiple prion strains (Table 1,
Figure 1). For C57BL/6 (C57BL/6JOlaHsd or C57BL/6J) highly
significant sex differences were observed for all four prion strains.
For both mouse-adapted scrapie prion strains the mean incubation
time in females was 4 or 2% (Chandler/RML and ME7
respectively) shorter than in males (p=0.05 and p=0.001) while
for both mouse-passaged BSE prion strains this was reversed with
the female mean incubation time being longer than for males (4
and 2%, p=0.0002 and p=0.0001 for I874 and MRC2-I9468
respectively). FVB/NHsd displayed a significant sex effect with
Chandler/RML (p=0.0007), ME7 (p=0.037) and MRC2-I9478
(P=0.013) but not for mouse passaged BSE (I874). These effects
are in the same direction as for C57BL/6 with the mean
incubation time in females being shorter for mouse-adapted
scrapie strains (7 and 3% for Chandler/RML and ME7
respectively) and the mean incubation times in females being
3% longer with MRC2-I9468.
PrP
C levels
In experimental mouse models, the level of PrP
C expression is
inversely correlated to incubation time. The shortest incubation
times are seen in transgenic models over-expressing mouse PrP
[25]. While Prnp null mice are resistant to prion disease, one copy
of Prnp restores susceptibility but with an increased incubation time
relative to wild type controls [26]. To determine whether
differences in endogenous PrP
C levels could explain the sex effects
seen in C57BL/6 and FVB/N mice, we measured total PrP
C in
10% brain homogenates for both males and females using a PrP
specific ELISA [27]. No differences were seen between the sexes or
between mouse strains (Figure 2).
Table 1. Prion incubation times.
RML/Scrapie (I856) ME7 (I9459) Mouse Passaged BSE (I874) MRC2 (I9468)
Male Female p-val Male Female p-val Male Female p-val Male Female p-val
C57BL/6JOlaHsd 14661( 2 0 ) 1 4 0 61 (21) 0.005 17361 (22) 18061 (20) 0.0002
C57BL/6J 16861 (10) 16460 (13) 0.001 17361 (5) 17760 (10) 0.0001
FVB/NHsd 13662( 1 5 ) 1 2 7 61 (18) 0.0007 15461 (14) 14962 (9) 0.037 15562 (13) 15762 (19) ns 14763 (8) 15262 (14) 0.013
NZW/OlaHsd 11061( 1 6 ) 1 0 7 62 (22) 0.006 13361 (15) 13261( 1 3 ) n s
RIIIS/J 13661( 1 7 ) 1 3 4 61 (17) ns 16462 (18) 16962( 2 1 ) n s
SJL/OlaHsd 12161( 1 9 ) 1 2 2 61 (18) ns 15263 (15) 15862( 2 2 ) n s
SWR/OlaHsd 13561( 1 9 ) 1 3 5 62 (17) ns 15362 (13) 15861( 1 4 ) n s
SM/J 12961( 2 7 ) 1 3 7 61 (20) ,0.0001 17161 (17) 17361( 1 2 ) n s
CAST/Ei 19365 (5) 18663 (3) ns 18469 (3) 18066( 6 ) n s
PERA/Kamei 14861( 1 3 ) 1 5 3 62 (13) ns 19166 (5) 206610 (12) ns
PWK/Pas 22465 (8) 214610 (4) ns 18163 (5) 18564( 8 ) n s
JU/FaCt 31764 (9) 31064 (15) ns 354613 (6) 398683 (2) ns
MAI/Pas 37264( 1 0 ) 3 4 8 64 (9) ns 32969 (4) 32167( 7 ) n s
Incubation times are given for prion transmissions following intra-cerebral inoculation and are displayed as the mean 6 sem given in days with the number of animals
per group given in parentheses. RML and Me7 represent two distinct strains of mouse-passaged scrapie and mouse BSE and MRC2 represent two different preparations
of mouse passaged BSE. For all prion strains, all groups of mice were inoculated with 1% brain homogenate made from the same stock of 10% brain homogenate. All
RML/scrapie and mouse passaged BSE transmissions were carried out in a conventional animal facility and ME7 and MRC2 transmissions were carried out in a specific-
pathogen-free facility. Where data were normally distributed groups were analysed statistically using a t-test. Where one or both of the groups did not pass a normality
test, a non-parametric Mann-Whitney test was used. ns denotes not significant (P.0.05).
doi:10.1371/journal.pone.0028741.t001
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To establish whether regions of the brain showed differential
susceptibility between males and females we compared the
pattern of PrP
Sc deposition, spongiosis, gliosis and neuronal loss
in groups of males and females (5–14 per group) for C57BL/6
and FVB/NHsd for Chandler/RML, ME7 and MRC2 prion
strains. Endocrine differences have been implicated as determi-
nants of sex effects in prion disease [19]. The pituitary was
unavailable for analysis as this is generally lost during the
removal of the brains, however, the hypothalamus was looked at
in detail. For all groups no significant differences were seen
between males and females or between the mouse strains
(Figure 3 and figures 4 and S1). For both males and females the
patterns of neuropathology were characteristic of the prion
strains used.
Prion strain typing
In addition to neuropathological differences, the other important
feature for strain discrimination are the molecular characteristics of the
protease-resistant prion protein (PrP
Sc) as shown by immunoblotting.
We compared the pattern of PrP
Sc in end stage brains from males and
females (3 per group) for C57BL/6 and FVB/NHsd for Chandler/
RML, ME7 and MRC2 transmissions. In all cases the characteristic
PrP
Sc pattern for the prion strain was preserved and no differences
were observed between males and females (Figure 5, S2 and S3).
Materials and Methods
Mice
Commercially available inbred mouse lines were obtained from
Harlan, UK (Bicester, UK) or the Jackson Laboratory (Bar
Figure 1. C57BL/6 and FVB/N survival curves. Survival curves for prion transmissions to C57BL/6J (A–D) and FVB/NHsd (E–H) mice. A and E, Chandler/
RML prions; B and F, mouse passaged BSE prions; C and G, ME7 prions; D and H, MRC2 prions. % survival is shown on the y-axis and days post inoculation is
s h o w no nt h ex - a x i s .A l ld a t aa r es i g n i f i c a n t( P ,0.05) except for mouse-passaged BSE transmission to FVB/NHsd. Detailed values are given in Table 1.
doi:10.1371/journal.pone.0028741.g001
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from Jean-Louis Gue ´net (Institute Pasteur, Paris); JU/FaCt were a
gift from Bruce Cattanach (MRC Harwell, UK) and CAST/Ei
were obtained from the Mary Lyon Centre (MRC Harwell, UK).
Prion strains
All inocula were prepared as 1% (weight/volume) prion infected
brain homogenate in PBS made from the brains of terminally sick
mice. The mouse adapted scrapie prion strain Chandler/RML
(gift of A. Aguzzi, Institute of Neuropathology, University of
Zurich, Zurich) was generated by a single passage in CD-1 Swiss
mice [7]. A source of the ME7 mouse adapted prion strain was
obtained from the Institute of Animal Health, UK and further
passaged once in C57BL/6JOlaHsd mice. BSE tissues were
originally obtained from the Veterinary Laboratories Agency, UK
and passaged in inbred mice as previously described [28]. In brief,
both BSE preparations were derived from a pool of five brainstems
from naturally occurring cases of BSE. This material was passaged
twice in C57BL6/JOlaHsd mice to produce the inoculum I874.
This was further passaged in SJL/OlaHsd mice to produce the
strain MRC2 (I9468) [28].
Prion inoculation and phenotyping
Mice were anaesthetized with isofluorane/O2 and inoculated
intra-cerebrally into the right parietal lobe with 30 mlo fa1 %
prion infected brain homogenate as previously described [7]. Mice
were examined daily for neurological signs of prion disease and
were culled once a definitive diagnosis had been made or earlier if
showing signs of distress or loss of up to 20% of body weight.
Diagnostic criteria for clinical prion disease were as previously
described [29]. Non-specific early signs include agitation,
aggression, unusual gait and slight weight loss and more specific
early indicators include erect ears, rigid tail, un-groomed
appearance, slight hunched posture and clasping of hind limbs
when lifted. Definitive diagnosis was made on observation of one
confirmatory sign of prion disease and animals were culled at this
point. Confirmatory signs included ataxia, generalised tremor, loss
of righting reflex, limb paralysis, extensive pilo-erection or
sustained hunched posture. Incubation time was calculated
retrospectively and defined as the number of days from inoculation
to the onset of clinical signs. All sex difference comparisons were
from experiments that were performed at the same time with the
same inoculum with the same technicians recording neurological
observations. All procedures were conducted in accordance with
institutional and national regulations and standards on animal
welfare. Experiments were approved by the MRC Prion Unit
Animal Ethical Review Committee and carried out under UK
Home Office licences PPL 80/1639 and PPL 70/6454.
Immunohistochemistry
Mouse brains were fixed in 10% buffered formal saline (BFS)
and prion infectivity was inactivated by incubation in 98% formic
acid for one hour. Tissues were paraffin wax embedded, sectioned
Figure 2. PrP
C levels for male and female C57BL/6 and FVB/N
mice. PrP
C levels (ug/ml) were determined in triplicate using 10%
(weight/volume) brain homogenate for male (n=3) and female (n=3)
mice of each strain in a PrP specific ELISA. Data are shown normalised
by total protein content (ug/ml and 61000) as determined by a BCA
assay (mean 6 standard deviation). No significant differences were seen
between males and females or between strains.
doi:10.1371/journal.pone.0028741.g002
Figure 3. Histological features of Chandler/RML inoculated male and female FVB/N mice. Comparison of histological features between
male FVB/N (left panel, A–D) and female FVB/N mice (right panel, E–H) inoculated with Chandler/RML prions. Panels A and E show the PrP
Sc
distribution in a cross section of the brain and panels B–D and F–H are higher power views of the hypothalamus (boxed area). (B and F) mild
spongiosis (C and G) synaptic deposition of PrP
Sc (D and H) gliosis. Overall, the pattern of PrP
sc distribution, spongiosis or gliosis, shows no difference
between both groups. Scale bar corresponds to 2 mm (A, E), 80 mm (B, F) or 160 mm in all other panels.
doi:10.1371/journal.pone.0028741.g003
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stained with haematoxylin and eosin (H&E) for general examina-
tion and determination of spongiosis and neuronal loss. Prion
deposition was visualised with anti-PrP monoclonal antibody
ICSM35 (D-Gen Ltd, UK) and gliosis was determined with an
anti-glial fibrillary acid protein (GFAP) antibody (Dako UK, Ltd).
Western blotting
10% w/v brain homogenates in D-PBS were prepared by
ribolysing, benzonase treated, proteinase K digested (50 mg/ml of
proteinase K for 1 h at 37uC) and western blotted as described
previously [30]. Blots were probed with the anti-PrP monoclonal
antibody ICSM-35 (D-Gen Ltd, UK) in conjunction with an
alkaline-phosphatase-conjugated anti-mouse IgG secondary anti-
body (Sigma) and developed in chemiluminescent substrate (CDP-
Star; Tropix Inc).
Quantification of PrP
c by enzyme linked immunosorbent
assay (ELISA)
Endogenous levels of PrP
C were determined in 10% brain
homogenates by ELISA as previously described [27]. PrP
C was
captured by anti-PrP monoclonal antibody ICSM18 (D-Gen Ltd,
UK) and detected using biotinylated anti-PrP monoclonal
antibody ICSM35 (D-Gen Ltd, UK) and streptavidin-horseradish
Figure 4. PrP
Sc distribution in the brains of C57BL/6 and FVB/N mice. Comparison of prion protein staining between male (A, C, E, G) and
female (B, D, F, H) mice inoculated with ME7 prions (A–D) and MRC2 prions (E–H). A, B and E, F represent C57BL/6 mice and C, D and G, H represent
FVB/N mice. Overall, the pattern of PrP
Sc distribution shows no difference between male and females and is characteristic of the prion strain used.
Scale bar corresponds to 2.5 mm for all panels except for C and D where it corresponds to 3 mm.
doi:10.1371/journal.pone.0028741.g004
Figure 5. Western blot of PrP
Sc from the brains of C57BL/6 and
FVB/N mice following Chandler/RML transmission. Western blot
of proteinase-K treated 10% w/v brain homogenates (n=3 for both
males and females) immunoblotted with anti-PrP monoclonal antibody
ICSM-35 (D-Gen Ltd, UK). (A) C57BL/6 mice (B) FVB mice. The PrP
Sc from
both male and female brains is characteristic of the RML scrapie prion
strain and no sex differences are seen.
doi:10.1371/journal.pone.0028741.g005
Sex Effects in Prion Disease
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was determined with a Pierce BCA Protein Assay kit (Thermo
Scientific) according to the manufacturer’s instructions.
Statistical analysis
Statistical tests were carried out using GraphPad InStat
(GraphPad Software, Inc, California, USA). Where the group
incubation times passed a normality test (Kolmogorov-Smirnov),
data were evaluated using a two-tailed t-test. Where the normality
test was not passed the non-parametric Mann-Whitney test was
used.
Discussion
Sex effects have been implicated in prion disease incubation
time for many years, however, to date, these data have been
equivocal with few conclusions drawn. We have now presented a
comprehensive study with 12 different inbred lines of mice all of
which were challenged with a mouse-adapted scrapie strain of
prions (Chandler/RML) and mouse-adapted BSE (I874). In
addition, two mouse lines (C57BL/6 and FVB/N) were challenged
with ME7 and the mouse-adapted BSE strain, MRC2. Our data
show that sex can have a significant effect on incubation in some
instances. However, this is highly specific to the mouse and prion
strain combination. 8 of the 12 mouse strains used showed no sex
differences with either prion strain and two mouse strains (NZW
and SM) only showed a sex effect with the Chandler/RML prion
strain. C57BL/6 and FVB/N were the only mouse strains to show
sex differences with both mouse adapted scrapie and BSE. For
these two mouse lines, females had a shorter incubation time than
males when challenged with either Chandler/RML or ME7 but
this was reversed following inoculation with BSE derived prions.
This is broadly in agreement with previous studies showing that:
female C57BL/6N have a shorter incubation time following
inoculation with ME7 [19]; female Prnp
b mice (VM/Dk, IM/Dk
and MB/Dk) have a shorter incubation time than males following
challenge with the mouse adapted scrapie strain; shorter
incubation time for female NZW mice with Chandler/RML but
not ME7 prions [21,22]. The opposite finding was reported by
Abiola et al in C57BL/6J mice inoculated with ME7 [20]. Analysis
of combined data from 117 titration experiments with ten mouse
strains and seven different murine scrapie strains concluded that
female mice had on average a nine day shorter incubation time
[31]. Based on our data, we suggest that it is not appropriate to
pool data from different mouse and prion strains, however, it is
possible that the data of McLean and Bostock broadly agree with
our findings due to the predominance of C57 mice and the ME7
prion strain in their data set [31].
Few studies have looked at the effect of sex on prion disease
incubation time following inoculation with BSE. On primary
passage of BSE to C57 and RIII mice no sex differences were
observed although an X chromosome-cytoplasm interaction was
observed in the F1 backcross generation [10]. This contrasts with
the findings of Abiola et al who described a highly significant
increase in C57BL/6J and DBA/2J females on inoculation with
BSE [20]. Although both these studies used C57BL mice they
were a different sub-strain with C57BL/FaBtDk and C57BL/6J
used by Manolakou et al and Abiola et al respectively. The extent of
the similarity between these two sub-strains has not been
characterised but it is possible that this may be sufficient to
explain the contradictory findings. In our present study we looked
at mouse-passaged BSE and where significant differences were
observed, females showed an increase in incubation times relatives
to males. It may not be appropriate to compare data from BSE
primary passages with data from murine BSE strains as the
presence of a species barrier and subsequent strain adaptation may
significantly alter the sex effects.
Sex differences have also been reported for age of onset and
disease duration of the human prion diseases, vCJD and sporadic
CJD [19,23]. Kingsbury et al also reported an increased incubation
time in female B.10.AKM, C3H/SwSn and C3H/D1Sn mice
following inoculation with mouse-passaged sporadic CJD strain
K.Fu [21].
In this study we have used the number of days from inoculation
to the onset of clinical signs as our measure of incubation time. It is
also possible to measure incubation period as the time from
inoculation to the time of death and to measure the duration of the
disease. Using these alternative data it is possible that other sex
differences may be observed.
The reason for the observed sex differences is still unresolved. In
this study we have shown that there is no difference in the
endogenous levels of PrP
C between males and females that show
differences in incubation time with a range of prion strains. We
have also shown that there are no detectable differences between
males and females in terms of PrP
Sc deposition in the brain and
the pattern and extent of spongiosis, gliosis and neuronal loss. No
differences were seen in prion strain types between males and
females as determined by PrP
Sc pattern by immunoblotting.
Loeuillet et al investigated the effect of androgens on incubation
time by using castrated mice [19]. Castration negated the sex
effect after intracerebral inoculation but not following intraperi-
toneal inoculation suggesting that while androgens may play a role
other factors such as differential inactivation of genes on the X
chromosome are also likely to be important.
For some mouse inbred lines and prion strain combinations
there is a highly significant difference in incubation time with a
mean difference of up to 7%. While this effect is not seen with all
mouse lines, it is of particular importance in C57BL/6 and FVB/
N strains as these are commonly used for the generation of
knockout and transgenic mouse models. We therefore recommend
that when testing the effect of a modifying gene or therapeutic
agent on prion disease incubation time it is essential to use single
sex groups.
Supporting Information
Figure S1 Histological features of Chandler/RML inoc-
ulated male and female C57BL/6 mice. Comparison of
histological features between male C57BL/6/(left panel, A–D) and
female C57BL/6 mice (right panel, E–H) inoculated with
Chandler/RML prions. Panels A and E show the PrP
Sc
distribution in a cross section of the brain and panels B–D and
F-H are higher power views of the hypothalamus (boxed area). (B
and F) mild spongiosis (C and G) synaptic deposition of PrP
Sc (D
and H) gliosis. Overall, the pattern of PrP
Sc distribution, spongiosis
or gliosis, shows no difference between both groups. Scale bar
corresponds to 2 mm (A, E), 80 mm (B, F) or 160 mm in all other
panels.
(JPG)
Figure S2 Western blot of PrP
Sc from the brains of
C57BL/6 and FVB/N mice following Me7 transmission.
Western blot of proteinase-K treated 10% w/v brain homogenates
(n=3 for both males and females) immunoblotted with anti-PrP
monoclonal antibody ICSM-35 (D-Gen Ltd, UK). (A) C57BL/6
mice (B) FVB mice. The PrP
Sc from both male and female brains
is characteristic of the Me7 scrapie prion strain and no sex
differences are seen.
(TIF)
Sex Effects in Prion Disease
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Sc from the brains of
C57BL/6 and FVB/N mice following MRC2 transmis-
sion. Western blot of proteinase-K treated 10% w/v brain
homogenates (n=3 for both males and females) immunoblotted
with anti-PrP monoclonal antibody ICSM-35 (D-Gen Ltd, UK).
(A) C57BL/6 mice (B) FVB mice. The PrP
Sc from both male and
female brains is characteristic of the MRC2 prion strain and no
sex differences are seen.
(TIF)
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